BioSpace News Archive

First Biomimetic Model to Demonstrate Myelination of Human Nerve Cells with Human Schwann Cells

Medicenna Therapeutics Corp., a clinical stage immuno-oncology company, announced that it has received US$1,915,264 from the Cancer Prevention and Research Institute of Texas.

Sigilon Therapeutics presented preclinical data demonstrating the feasibility of cellular therapies for bleeding disorders developed with the company’s Shielded Living Therapeutics™ platform, which was designed to deliver functional cures for chronic diseases.

Personalized brain neuromodulation technology provides relief from debilitating migraine symptoms

Catalent, Inc. announced that it has significantly expanded the capacity of its global spray drying operations through an agreement with Sanofi Active Ingredient Solutions, an industrial platform of Sanofi, under which Sanofi will provide Catalent with access to spray drying manufacturing services for Catalent’s customers at Sanofi’s Haverhill, U.K. facility.

Premier Media Services Inc., dba LenisUSA, announces the Lenis™ Needle Free Safety Syringe Injection System has been awarded an Innovative Technology contract from Vizient, the largest member-driven health care performance improvement company in the United States.

Nature Research Journal highlights data supporting the therapeutic potential of PMN310 against the toxic oligomer form of amyloid beta, a root cause of Alzheimer’s disease

CSI Laboratories (CSI) and Synergy Capital Investments (Synergy) announced the transition of a convertible note to equity stake in CSI, a state of the art, specialized cancer diagnostic center.

Consulting Hypnotists Help Ordinary People with Ordinary Problems

Sandoz is committed to helping people access high quality healthcare at affordable prices, with strong focus on areas of unmet patient need